Normal view MARC view ISBD view

[Effect of losartan on produce of sera autoantibodies to angiotensin II-1 receptor in renovascular hypertension rats]. [electronic resource]

By:

Zhi, Jian-Ming

Contributor(s):

Producer: 20121207Description: 43-6 p. digitalISSN:

1000-6834

Subject(s):

In: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology vol. 19

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: English Abstract; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

There are no comments on this title.

to post a comment.

Back to results

1 Immunotherapy for head and neck cancer: latest developments and clinical potential.
by Bauml, Joshua M
2 Immunotherapy for head and neck cancer: where are we now and where are we going?
by Bauml, Joshua M
3 PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.
by Bagley, Stephen J
4 The association between fatigue and pain symptoms and decreased physical activity after cancer.
by Romero, Sally A D
5 Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.
by Aggarwal, Charu
6 Barriers to physical activity: a study of academic and community cancer survivors with pain.
by Romero, Sally A D
7 Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.
by Bauml, Joshua M
8 Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
by Katz, Sharyn I
9 Post-treatment weight change in oral cavity and oropharyngeal squamous cell carcinoma.
by Zhang, Zi
10 Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety".
by Bauml, Joshua M
11 Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial.
by Bauml, Joshua M
12 Impact of
by Bange, Erin
13 Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
by Bauml, Joshua M
14 Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer.
by Gershowitz, Jared
15 Influence of
by Aggarwal, Charu
16 Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
by Aggarwal, Charu
17 Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
by Bauml, Joshua M
18 The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation.
by Chao, Hann-Hsiang
19 Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.
by Aggarwal, Charu
20 Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries.
by Hatten, Kyle M